Evaluation of the Optimal Manufacturing Protocols and Therapeutic Properties of Mesenchymal Stem/Stromal Cells Derived from Wharton’s Jelly

Evaluation of the Optimal Manufacturing Protocols and Therapeutic Properties of Mesenchymal Stem/Stromal Cells Derived from Wharton’s Jelly

Wharton’s jelly (WJ) from the umbilical cord (UC) is a good source of mesenchymal stem/stromal cells (MSCs), which can be isolated and used in therapy. Current knowledge shows that even small changes in the cell environment may result in obtaining a subpopulation of cells with different therapeutic...

Full description

Bibliographic Details
Main Authors: Monika Sypecka, Aleksandra Bzinkowska, Dorota Sulejczak, Filip Dabrowski, Anna Sarnowska
Format: Article
Language:English
Published: MDPI AG 2022-12-01
Series:International Journal of Molecular Sciences
Subjects:
Wharton’s jelly
mesenchymal stem/stromal cells
cerebrospinal fluid
stem cell therapy
neural differentiation
Online Access:https://www.mdpi.com/1422-0067/24/1/652

Similar Items

Similar Items